Elizabeth Pando
Vall d'Hebron Hospital Universitari, Universitat Autònoma de Barcelona
Papers
6
Total Citations
129
H-Index
5
About
Elizabeth Pando is a leading surgical researcher whose work centers on advancing minimally invasive pancreatic surgery, particularly through the comparison of robotic and laparoscopic techniques. Her major contributions include landmark studies that provide critical evidence on the safety, efficacy, and cost-effectiveness of robot-assisted distal pancreatectomy (RDP) versus laparoscopic distal pancreatectomy (LDP) for patients with resectable pancreatic cancer. Notably, her 2023 international retrospective cohort study, with 41 citations, demonstrated that RDP is a safe and effective alternative to LDP, addressing a key gap in multicenter data. She has also pioneered the use of benchmarking—a quality improvement tool—to establish best achievable outcomes for spleen-preserving and splenectomy-inclusive distal pancreatectomies, with two 2022 studies garnering 32 and 29 citations respectively. Her work on the ROBOCOSTES trial, which evaluates cost-effectiveness, further underscores her impact by integrating economic considerations into surgical decision-making. With a growing citation record and contributions to pan-European registry data, Pando is shaping the future of pancreatic surgery, offering students and researchers a rigorous, evidence-based framework for adopting robotic techniques.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6